Internal Medicine, Infectious Disease · Brooklyn, NY
NPI
1922208743
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
450 Clarkson Ave, Box 1240
Brooklyn, NY, 11203
Phone (718) 270-4180
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,459
42 services
Medicare patients, 2024
26
Average age 69
Drug cost, 2024
$1.4M
1,368 prescriptions
Company payments, 2025
$23K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica E Yager was code 99232 (hospital e&m - subsequent), 17 times for 13 patients. In total Jessica E Yager billed 42 services in 4 codes, and Medicare paid $4,459.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 17 | 13 | $69.51 | $1,182 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $152.69 | $1,985 |
By year: 2022 $4,197 for 37 services; 2023 $5,726 for 53 services; 2024 $4,459 for 42 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica E Yager prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 152 prescriptions and refills. In total Jessica E Yager wrote 1,368 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 152 | 166 | 26 | $630K |
| Atorvastatin Calcium Generic | 68 | 116 | 16 | $479 |
| Gabapentin Generic | 50 | 57 | 11 | $398 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 47 | 49 | 13 | $1,633 |
| Rosuvastatin Calcium Generic | 41 | 49 | Under 11 | $179 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 39 | 39 | Under 11 | $150K |
| Hydrochlorothiazide Generic | 31 | 43 | Under 11 | $41.72 |
| Metoprolol Succinate Generic | 31 | 45 | Under 11 | $343 |
| Fluticasone Propionate Generic | 30 | 30 | Under 11 | $231 |
| Lisinopril Generic | 28 | 42 | Under 11 | $108 |
| Losartan Potassium Generic | 27 | 45 | Under 11 | $132 |
| Tivicay Dolutegravir Sodium | 26 | 34 | Under 11 | $75K |
| Prezcobix Darunavir/Cobicistat | 25 | 25 | Under 11 | $64K |
| Trulicity Dulaglutide | 24 | 24 | Under 11 | $22K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 23 | 23 | Under 11 | $3,730 |
Brand drugs: 492 claims; generic drugs: 800 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica E Yager $23K ($23K in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $23K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.